公开(公告)号：US20180318357A1

公开(公告)日：2018-11-08

申请号：US15773496

申请日：2016-11-03

Applicant: DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY

Inventor： Kyeong Min LEE ,  Won Bae JEON ,  Jung Hee KIM

IPC: A61K35/39 ,  A61K38/39 ,  A61P3/10

CPC classification number: A61K35/39 ,  A61K38/39 ,  A61P3/10 ,  C07K7/00 ,  C07K14/78 ,  A61K2300/00

Abstract: The present invention relates to a pharmaceutical composition for treating diabetes, which includes a pancreatic islet cell and an elastin-like artificial extracellular matrix (REP), and more particularly, to a pharmaceutical composition for treating diabetes, in which pancreatic islet cells are reacted with an elastin-like artificial extracellular matrix and then the resulting cells are administered along with the elastin-like artificial extracellular matrix, thus increasing a survival rate of the transplanted pancreatic islet cells, rapidly restoring a blood glucose level to normal, and maintaining the restored blood glucose level for a long period of time, and, accordingly, diabetes may be more effectively treated.